TipRanks
Go Ultimate55% OFF

AbbVie (ABBV) Ratios

AbbVie Ratios

MX:ABBV's free cash flow for Q2 2026 was $3.11B. For the 2026 fiscal year, MX:ABBV's free cash flow was decreased by $-322.00M and operating cash flow was $3.44B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.670.660.870.960.79
Quick Ratio0.560.550.760.840.70
Cash Ratio0.120.140.340.310.28
Solvency Ratio0.090.100.110.170.15
Operating Cash Flow Ratio0.440.490.600.840.65
Short-Term Operating Cash Flow Coverage2.182.763.185.801.80
Net Current Asset Value$ -108.13B$ -106.22B$ -91.31B$ -93.06B$ -103.17B
Leverage Ratios
Debt-to-Assets Ratio0.520.500.450.460.53
Debt-to-Equity Ratio-21.1220.405.803.725.03
Debt-to-Capital Ratio1.050.950.850.790.83
Long-Term Debt-to-Capital Ratio1.060.950.830.770.81
Financial Leverage Ratio-40.9740.6513.008.049.51
Debt Service Coverage Ratio1.311.611.683.451.49
Interest Coverage Ratio6.943.255.748.127.40
Debt to Market Cap0.170.210.220.220.32
Interest Debt Per Share40.5639.9435.2637.5045.20
Net Debt to EBITDA3.624.182.752.272.83
Profitability Margins
Gross Profit Margin70.24%69.99%62.42%70.00%68.96%
EBIT Margin15.52%11.58%15.60%27.06%27.42%
EBITDA Margin28.82%26.47%31.61%41.64%42.59%
Operating Profit Margin32.85%16.22%23.49%31.21%31.89%
Pretax Profit Margin10.79%6.60%11.51%23.21%23.11%
Net Profit Margin6.91%7.59%8.95%20.39%20.54%
Continuous Operations Profit Margin6.92%7.61%8.97%20.40%20.55%
Net Income Per EBT64.06%115.12%77.81%87.82%88.86%
EBT Per EBIT32.84%40.67%48.99%74.39%72.47%
Return on Assets (ROA)3.15%3.17%3.61%8.53%7.88%
Return on Equity (ROE)-129.24%128.66%46.94%68.60%74.91%
Return on Capital Employed (ROCE)22.16%9.48%13.17%16.58%16.10%
Return on Invested Capital (ROIC)12.97%8.85%9.56%14.02%12.85%
Return on Tangible Assets9.25%10.66%10.39%30.19%30.22%
Earnings Yield1.04%1.36%1.77%4.14%4.82%
Efficiency Ratios
Receivables Turnover4.865.164.875.165.63
Payables Turnover5.075.745.545.946.05
Inventory Turnover3.684.044.984.875.58
Fixed Asset Turnover9.6110.9710.8911.7611.00
Asset Turnover0.460.420.400.420.38
Working Capital Turnover Ratio-4.47-6.26-18.37-13.92-9.56
Cash Conversion Cycle102.3897.4382.3184.2869.95
Days of Sales Outstanding75.1370.7574.9670.7664.80
Days of Inventory Outstanding99.2790.2873.2975.0265.44
Days of Payables Outstanding72.0263.5965.9461.5060.30
Operating Cycle174.40161.02148.24145.77130.24
Cash Flow Ratios
Operating Cash Flow Per Share10.7310.6312.9214.0812.87
Free Cash Flow Per Share10.0410.0812.4813.6912.42
Dividend Paid and CapEx Coverage Ratio1.481.572.022.322.27
Capital Expenditure Coverage Ratio15.6819.3129.3935.8928.94
Operating Cash Flow Coverage Ratio0.280.280.380.390.29
Operating Cash Flow to Sales Ratio0.310.330.420.430.41
Free Cash Flow Yield4.40%5.67%8.05%8.47%9.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio96.4174.0456.3424.1820.76
Price-to-Sales (P/S) Ratio6.635.585.044.934.26
Price-to-Book (P/B) Ratio-123.9694.5426.4516.5915.55
Price-to-Free Cash Flow (P/FCF) Ratio22.7517.6312.4211.8010.90
Price-to-Operating Cash Flow Ratio21.3016.7212.0011.4710.52
Price-to-Earnings Growth (PEG) Ratio-77.13-6.13-0.969.220.15
Enterprise Value Multiple26.6125.2618.7114.1112.85
Enterprise Value469.18B376.67B321.29B341.20B307.49B
EV to EBITDA26.6125.2618.7114.1112.85
EV to Sales7.676.695.925.885.47
EV to Free Cash Flow26.3321.1214.5614.0713.98
EV to Operating Cash Flow24.6520.0314.0713.6813.50
Tangible Book Value Per Share-51.58-51.81-43.84-46.48-52.48
Shareholders’ Equity Per Share-1.841.885.869.748.71
Tax and Other Ratios
Effective Tax Rate0.36-0.150.220.120.11
Revenue Per Share34.4831.8530.7232.7831.75
Net Income Per Share2.382.422.756.686.52
Tax Burden0.641.150.780.880.89
Interest Burden0.700.570.740.860.84
Research & Development to Revenue0.150.230.140.110.14
SG&A to Revenue0.230.260.000.000.00
Stock-Based Compensation to Revenue0.020.020.010.010.01
Income Quality4.504.394.742.111.97

Currency in USD